DalsnaFinance

Seegene USA Receives FDA Emergency Use Authorization for Multiplex PCR Assay, Advancing Differential Diagnosis of HSV-1&2, VZV, and Monkeypox Virus for Ulcerative Skin Lesions

Markets PR Newswire By PR Newswire 21 Jul 2026 13:00 1 min read
Seegene USA Receives FDA Emergency Use Authorization for Multiplex PCR Assay, Advancing Differential Diagnosis of HSV-1&2, VZV, and Monkeypox Virus for Ulcerative Skin Lesions

Seegene USA's Allplex™ HSV-1&2/VZV/MPXV Assay receives Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) The multiplex real-time PCR assay is designed to simultaneously detect and differentiate herpes simplex virus types 1 and 2 (HSV-1 and HSV-2),...

Seegene USA's Allplex™ HSV-1&2/VZV/MPXV Assay receives Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) The multiplex real-time PCR assay is designed to simultaneously detect and differentiate herpes simplex virus types 1 and 2 (HSV-1 and HSV-2),...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.